COVID-19 Therapies

• COVID-19: Patient Education Before Casirivimab and Imdevimab or Bamlanivimab and Etesevimab or Sotrovimab (FDA EUA)

• COVID-19: Patient Education After Casirivimab and Imdevimab by Subcutaneous Injection

• COVID-19: Patient Education after Sotrivimab or Bebtelovimab

• COVID-19: Patient Education After Tixagevimab and Cilgavimab by Intramuscular Injection

• COVID-19: Patient Education Before EVUSHELD™ (tixagevimab co-packaged with cilgavimab) (FDA EUA)

• Donating Plasma after Recovery from Coronavirus (COVID-19)

• Emergency Use Authorization (EUA) of Bebtelovimab for Coronavirus Disease 2019 (COVID-19): Fact Sheet for Patients, Parents, and Caregivers

• Emergency Use Authorization (EUA) of Sotrovimab for the Treatment of Coronavirus Disease 2019 (COVID-19): Fact Sheet for Patients, Parents, and Caregivers

• Lagevrio (molnupiravir) Capsules For Coronavirus Disease 2019 (COVID-19) EUA Fact Sheet

• Paxlovid For Coronavirus Disease 2019 (COVID-19) EUA Fact sheet

• Preventative Therapy after Close Contact Exposure to COVID-19 (Monoclonal Antibody Therapy)

• Remdesivir for Coronavirus Disease (COVID-19)

• Remdesivir for Coronavirus Disease (COVID-19) (Outpatient)

• What is Monoclonal Antibody Treatment? (For COVID-19 Positive Children and Adults)

Back to the COVID-19 page